Exam (elaborations)

Test Bank for Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition by Teri Moser Woo

88 views 4 purchases

Course
Advance nursing

Institution
Advance Nursing

Test Bank for Pharmacotherapeutics for Advanced Practice Nurse Prescribers 6e 6th Edition by Teri Moser Woo, Wendy L. Wright. Full Chapters test bank are included with answers - Chapter 1 to 57 I. THE FOUNDATION 1. The Role of the Nurse Practitioner as Prescriber 2. Review of the Basic Princip...

[Show more]

Preview 4 out of 213 pages

View example

Uploaded on June 8, 2024
Number of pages 213
Written in 2023/2024
Type Exam (elaborations)
Contains Questions & answers

pharmacotherapeutics
advanced
practice
nurse
prescribers
6th
edition
teri
woo
multiple choice
mcqs
question bank
quiz bank
6e
test bank
practice quizzes

Institution Advance nursing
Course Advance nursing

StepsSol

Member since 1 year 1769 documents sold

129

CA$56.28

Added

Add to cart

Add to wishlist

100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached

Woo 1 Pharmacotherapeutics for APN Prescribers, 6e Ch01 Chapter 1. The Role of the Advanced Practice Nurse as Prescriber MULTIPLE CHOICE 1. Nurse practitioner prescriptive authority is regulated by: A. The National Council of State Boards of Nursing B. The U.S. Drug Enforcement Administration C. The State Board of Nursing for each state D. The State Board of Pharmacy ANS: C PTS: 1 2. The benefits to the patient of having an advanced practice registered nurse (APRN) prescriber include: A. Nurses know more about pharmacology than other prescribers because they take it both in their basic nursing program and in their APRN program. B. Nurses care for the patient from a holistic approach and include the patient in decision-making regarding their care. C. APRNs are less likely to prescribe narcotics and other controlled substances. D. APRNs are able to prescribe independently in all states, whereas a physician’s assistant needs to have a physician supervising their practice. ANS: B PTS: 1 3. Clinical judgment in prescribing includes: A. Factoring in the cost to the patient of the medication prescribed B. Always prescribing the newest medication available for the disease process C. Handing out drug samples to poor patients D. Prescribing all generic medications to cut costs ANS: A PTS: 1 4. The process for choosing an effective drug for a disorder includes: A. Asking the patient what drug they think would work best for them B. Consulting nationally recognized guidelines for disease management C. Prescribing medications that are available as samples before writing a prescription D. Following U.S. Drug Enforcement Administration guidelines for prescribing ANS: B PTS: 1 5. Nonintentional nonadherence of drug therapy may occur due to: A. Belief that medication does not work B. Adverse drug reactions C. Chronic conditions that require daily therapy D. Forgetfulness or distraction ANS: D PTS: 1 Woo 1 Pharmacotherapeutics for APN Prescribers, 6e Ch02 Chapter 2. Review of Basic Principles of Pharmacology MULTIPLE CHOICE 1. A patient’s nutritional intake and laboratory results reflect hypoalbuminemia. This is critical to prescribing because: A. Distribution of drugs to target tissue may be affected. B. The solubility of the drug will not match the site of absorption. C. There will be less free drug available to generate an effect. D. Drugs bound to albumin are readily excreted by the kidneys. ANS: A PTS: 1 2. Drugs that have a significant first-pass effect: A. Must be given by the enteral (oral) route only B. Bypass the hepatic circulation C. Are rapidly metabolized by the liver and may have little, if any, desired action D. Are converted by the liver to more active and fat-soluble forms ANS: C PTS: 1 3. The route of excretion of a volatile drug will likely be the: A. Kidneys B. Lungs C. Bile and feces D. Skin ANS: B PTS: 1 4. A major disadvantage to IV administration is that: A. First-pass metabolism is eliminated. B. Needles and sterility are required. C. Absorption of the drug cannot be slowed after administration. D. It is significantly more expensive than other routes. ANS: C PTS: 1 5. The nurse practitioner (NP) chooses to give cephalexin every 8 hours based on knowledge of the drug’s: A. Propensity to go to the target receptor B. Biological half-life C. Pharmacodynamics D. Safety and side effects ANS: B PTS: 1 6. Deferasirox is a chelating agent used to treat iron overload by binding iron to render it biologically inactive. This is best characterized as a(n): Woo 2 Pharmacotherapeutics for APN Prescribers, 6e Ch02 A. Nonreceptor mechanism B. Partial agonist C. Full agonist D. Noncompetitive antagonist ANS: A PTS: 1 7. The point in time on the drug concentration curve that indicates the first sign of a therapeutic effect is the: A. Minimum adverse effect level B. Peak of action C. Onset of action D. Therapeutic range ANS: C PTS: 1 8. Phenytoin requires that a trough level be drawn. Peak and trough levels are done: A. When the drug has a wide therapeutic range B. When the drug will be administered for a short time only C. When there is a high correlation between the dose and saturation of receptor sites D. To determine if a drug is in the therapeutic range ANS: D PTS: 1 9. A laboratory result indicates that the peak level for a drug is above the minimum toxic concentration. This means that the: A. Concentration will produce therapeutic effects. B. Concentration will produce an adverse response. C. Time between doses must be shortened. D. Duration of action of the drug is too long. ANS: B PTS: 1 10. Drugs that are receptor agonists may demonstrate what property? A. Irreversible binding to the drug receptor site B. Up-regulation with chronic use C. Desensitization or down-regulation with continuous use D. Inverse relationship between drug concentration and drug action ANS: C PTS: 1 11. Drugs that are receptor antagonists, such as beta blockers, may cause: A. Down-regulation of the drug receptor B. An exaggerated response if abruptly discontinued C. Partial blockade of the effects of agonist drugs D. An exaggerated response to competitive drug agonists ANS: B PTS: 1 Woo 3 Pharmacotherapeutics for APN Prescribers, 6e Ch02 12. Factors that affect gastric drug absorption include: A. Liver enzyme activity B. Protein-binding properties of the drug molecule C. Lipid solubility of the drug D. Ability to chew and swallow ANS: C PTS: 1 13. Drugs administered via IV: A. Need to be lipid soluble in order to be easily absorbed B. Begin distribution into the body immediately C. Are easily absorbed if they are nonionized D. May use pinocytosis to be absorbed ANS: B PTS: 1 14. When a medication is added to a regimen for a synergistic effect, the combined effect of the drugs is: A. The sum of the effects of each drug individually B. Greater than the sum of the effects of each drug individually C. Less than the effect of each drug individually D. Not predictable, as it varies with each individual ANS: B PTS: 1 15. Which of the following statements about bioavailability is true? A. Bioavailability issues are especially important for drugs with narrow therapeutic ranges or sustained-release mechanisms. B. All brands of a drug have the same bioavailability. C. Drugs that are administered more than once a day have greater bioavailability than drugs given once daily. D. Combining an active drug with an inert substance does not affect bioavailability. ANS: A PTS: 1 16. Which of the following statements about the major distribution barriers (blood–brain or fetal–placental) is true? A. Water soluble and ionized drugs cross these barriers rapidly. B. The blood–brain barrier slows the passage of many drugs into and out of brain cells. C. The fetal–placental barrier protects the fetus from drugs taken by the mother. D. Lipid-soluble drugs do not pass these barriers and are safe for pregnant women. ANS: B PTS: 1 17. Drugs are metabolized mainly by the liver via phase I or phase II reactions. The purpose of both of these types of reactions is to: A. Inactivate prodrugs before they can be activated by target tissues

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller StepsSol. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for CA$56.28. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

81989 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling

Exam (elaborations)

Test Bank for Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition by Teri Moser Woo

Document information

Subjects

Written for

Seller

Reviews received

Content preview